UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050391
Receipt number R000057379
Scientific Title Evaluation of prognosis of treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation
Date of disclosure of the study information 2023/02/23
Last modified on 2023/02/21 00:51:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of prognosis of treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation

Acronym

Prognosis of AIC after ablation

Scientific Title

Evaluation of prognosis of treatment with catheter ablation for patients with arrhythmia-induced cardiomyopathy caused by atrial fibrillation

Scientific Title:Acronym

Prognosis of AIC after ablation

Region

Japan


Condition

Condition

Atrial fibrillation and heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aimed to explore the clinical outcomes in arrhythmia-induced cardiomyopathy patients

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cardiovascular death or hospitalization due to heart failure. Moreover, the composite endpoint was defined as cardiovascular death or hospitalization due to heart failure.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with AF and reduced LVEF (<50%) underwent initial AF ablation

Key exclusion criteria

patients with severe old myocardial infarction

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Tada

Organization

University of Fukui

Division name

Department of Cardiovascular Medicine, Faculty of Medical Sciences

Zip code

910-1193

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui

TEL

+81-776-61-8800

Email

daisetsu@u-fukui.ac.jp


Public contact

Name of contact person

1st name Daisetsu
Middle name
Last name Aoyama

Organization

University of Fukui

Division name

Department of Cardiovascular Medicine, Faculty of Medical Sciences

Zip code

910-1193

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui

TEL

+81-776-61-8800

Homepage URL


Email

daisetsu@u-fukui.ac.jp


Sponsor or person

Institute

University of Fukui

Institute

Department

Personal name



Funding Source

Organization

University of Fukui

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Fukui

Address

23-3 Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui

Tel

+81-776-61-8800

Email

daisetsu@u-fukui.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 02 Month 20 Day

Date of IRB

2022 Year 12 Month 21 Day

Anticipated trial start date

2023 Year 02 Month 20 Day

Last follow-up date

2023 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study uses data from multiple hospital as follow; University of Fukui, Hikone Municipal Hospital, and Hikone Municipal Hospital.


Management information

Registered date

2023 Year 02 Month 21 Day

Last modified on

2023 Year 02 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057379


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name